RARA CRAFT DATABASE for FDA Medical Devices
510(k)K162726

FDA DEVICE FACTS

Exactech® Equinoxe® Preserve Stem

Exactech, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEFebruary 1, 2017PRODUCT CODEPHX

Indications for use

The Equinoxe Preserve Stems are indicated for use in skeletally mature individuals with degenerative diseases of the glenohumeral joint where anatomic total arthroplasty, anatomic hemi-arthroplasty, or reverse total arthroplasty is determined by the surgeon to be the preferred method of treatment. Clinical indications for anatomic total arthroplasty and anatomic hemi-arthroplasty are as follows:  Rheumatoid arthritis, osteoarthritis, osteonecrosis or post-traumatic degenerative problems  Congenital abnormalities in the skeletally mature  Primary and secondary necrosis of the humeral head.  Pathologies where arthrodesis or resectional arthroplasty of the humeral head are not acceptable  Revisions of humeral prostheses when other treatments or devices have failed (where adequate fixation can be achieved)  To restore mobility from previous procedures (e.g. previous fusion) The Equinoxe Preserve Stems are additionally indicated for use in reverse total arthroplasty in skeletally mature individuals with degenerative diseases of the glenohumeral joint and a grossly deficient, irreparable rotator cuff or a failed glenohumeral joint replacement with loss of rotator cuff function resulting in superior migration of the humeral head. The patient must be anatomically and structurally suited to receive the implants and a functional deltoid muscle is necessary. The Equinoxe Preserve Stems are intended for press-fit applications but may be used with bone cement at the discretion of the surgeon.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 31, 2026